Články s príkazom na verejný prístup - Zdenka HaskovaĎalšie informácie
Nedostupné nikde: 1
Predictors of as-needed ranibizumab injection frequency in patients with macular edema following retinal vein occlusion
G Yiu, D Huang, Y Wang, Z Wang, M Yang, Z Haskova
American Journal of Ophthalmology 249, 74-81, 2023
Príkazy: US National Institutes of Health
Dostupné niekde: 8
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
Príkazy: US National Institutes of Health, Juvenile Diabetes Research Foundation
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
S Srivastava, D Pelloso, H Feng, L Voiles, D Lewis, Z Haskova, ...
Cancer immunology, immunotherapy 62, 1073-1082, 2013
Príkazy: US National Institutes of Health
Baseline predictors of 12-month treatment response to ranibizumab in patients with wet age-related macular degeneration
CD Regillo, BG Busbee, AC Ho, B Ding, Z Haskova
American journal of ophthalmology 160 (5), 1014-1023. e2, 2015
Príkazy: US National Institutes of Health
Spectral-domain OCT predictors of visual outcomes after ranibizumab treatment for macular edema resulting from retinal vein occlusion
G Yiu, RJ Welch, Y Wang, Z Wang, PW Wang, Z Haskova
Ophthalmology Retina 4 (1), 67-76, 2020
Príkazy: US National Institutes of Health
Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection
P Hamrah, Z Haskova, AW Taylor, Q Zhang, BR Ksander, MR Dana
Transplantation 88 (2), 180-187, 2009
Príkazy: US National Institutes of Health
Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activation
CB Woda, S Bruneau, AL Mak, Z Haskova, K Liu, CC Ghosh, DM Briscoe
Biochemical and biophysical research communications 519 (4), 667-673, 2019
Príkazy: US National Institutes of Health
Efficacy, durability, and safety of faricimab in diabetic macular edema: 2-year results from the phase 3 YOSEMITE and RHINE trials
JI Lim, JA Wells, DA Eichenbaum, CJ Danzig, K Asik, Z Haskova, ...
Investigative Ophthalmology & Visual Science 63 (7), 3850-3850, 2022
Príkazy: US National Institutes of Health
Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema
AN Antoszyk, KW Tarnowski, K Basu, JS Ehrlich, Z Haskova
Ophthalmology Retina 4 (10), 1034-1036, 2020
Príkazy: US National Institutes of Health
Informácie o zverejnení a financovaní sú automaticky vyberané počítačovým programom